Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
Status:
Completed
Trial end date:
2017-04-13
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, three-period, cross-over study to investigate the effect
of sumatriptan (Imitrex) 100 mg on the pharmacodynamics and pharmacokinetics of lasmiditan
200 mg.
Phase:
Phase 1
Details
Lead Sponsor:
CoLucid Pharmaceuticals Eli Lilly and Company
Collaborators:
CoLucid Pharmaceuticals SNBL Clinical Pharmacology Center, Inc.